Advancements in Preventing Catheter Related Bloodstream Infections: A Growing Market Frontier | TauroPharm GmbH, Fresenius Medical Care, AstraZeneca Pharma India Ltd

Market Overview:

Catheter related blood stream infections occur when bacteria or other germs enter the bloodstream through an intravascular catheter. Catheters used for intravenous infusions, total parenteral nutrition, hemodialysis, chemotherapy, and blood transfusions can become contaminated. If not promptly diagnosed and treated, CRBSIs can become life-threatening.

Market Dynamics:

The catheter related blood stream infection market is primarily driven by the increasing prevalence of hospital-acquired infections. According to the Centers for Disease Control and Prevention, approximately 250,000 cases of central line-associated bloodstream infections occur in the U.S. each year, and those infections contribute to around 31,000 deaths. In addition, the rising geriatric population who are more susceptible to such infections is also fueling the market growth. Furthermore, advancement in diagnosis and treatment of CRBSIs with the introduction of novel diagnostic tools and anti-infective catheters is projected to offer lucrative opportunities for market players over the forecast period.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/4805

Catheter Related Blood Stream Infection Market Drivers

Increasing Hospital Admissions and Healthcare Expenditure is Driving the Growth of Catheter Related Blood Stream Infection Market

There has been a significant rise in the number of hospital admissions globally due to increasing prevalence of chronic diseases like cancer, cardiovascular disease, diabetes and others. With the increasing burden of diseases, healthcare spending has also risen considerably. As catheter insertion is a commonly prescribed procedure in hospitals, rise in patient volume naturally increases the risk of catheter-related infections. According to WHO, nearly 15% of patients admitted to acute care hospitals at any given time will acquire at least one healthcare-associated infection. This rising disease burden and hospitalization rates have directly contributed to the growth of the CRBSI market.

Advancements in Catheter Technology and Diagnostic Tools are Fueling Market Expansion

Manufacturers are investing heavily in R&D to develop novel catheter technologies and diagnostic tools to minimize the risk of catheter-associated infections. Some of the recent innovations include antimicrobial coatings, antibiotic impregnations, needleless connector systems etc. Development of rapid and accurate diagnostic tests for early detection of CRBSIs is also boosting the market. Nanotechnology and surface modifications are being explored to make catheters resistant to infections. Growing focus on prevention has led to introduction of evidence-based guidelines for proper insertion and maintenance of vascular access devices. Adoption of such advanced products and adherence to guidelines will help reduce CRBSIs significantly over the coming years.

Catheter Related Blood Stream Infection Market Restrain

Lack of Reimbursement and Healthcare Infrastructure in Developing Regions Hinders Market Growth

Despite rising incidence, CRBSIs remain an under-reimbursed condition in most countries due to complex nature of attribution of infection to catheterization procedure. In developing regions like Asia Pacific and Latin America, lack of proper healthcare infrastructure and access poses major challenges for catheter insertion as well as prevention, diagnosis and management of associated infections. Non-availability of advanced catheters and diagnostic tests further aggravates the situation. Limited funds for healthcare make it difficult for government and private bodies to prioritize investment in this domain. Absence of national guidelines and protocols also poses a restrain. Unless these regions witness sustained economic growth leading to stronger reimbursement policies and healthcare systems, the full market potential may not be realized in the near future.

Catheter Related Blood Stream Infection Market Opportunity

Increasing Popularity of Home Healthcare Presents Significant Growth Prospects

The global home healthcare market has been rising steadily over the past decade, with patients increasingly opting for long-term catheter care outside the hospital setup. Self-catheterization and home healthcare services lower the risk of hospital acquired infections while improving quality of life and comfort for patients. This represented an excellent opportunity for manufacturers to introduce easy-to-use catheters and adjuncts aimed at home care. At the same time, developing simple and affordable diagnostic tests that can be used at home without supervision becomes important to promptly detect and treat infections. Technologies like telemedicine and remote monitoring also help optimize home catheter management. With the ongoing pandemic favoring home treatments over hospital visits, this segment is likely to generate higher revenues for CRBSI market players in the future.

Catheter Related Blood Stream Infection Market Trends

Rising Adoption of Antimicrobial Approaches Will Remain Key Trend in the CRBSI Market

One of the most important trends observed in this market in the recent past is the increasing preference for catheters coated or impregnated with antimicrobial agents ranging from antibiotics to antiseptics and novel formulations. This can help prevent colonization of microbes at the insertion site. Additionally, connectors and hubs containing antimicrobial properties that minimize intraluminal flow of microbes during line access are gaining traction. Manufacturers are innovating extensively in this domain by leveraging material science, nanotechnology and surface engineering principles. Going forward, CRBSI prevention approaches will focus more on engineering-based solutions rather than pharmaceutical interventions alone. The advanced technologies allow catheters to resist infections over extended usage durations compared to traditional products. Wider availability of such antimicrobial catheters and connectors can substantially curb the rising economic burden of CRBSIs worldwide.

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Catheter Related Blood Stream Infection companies, key tactics followed by Leading Key Players:

◘ Citius Pharmaceuticals
◘ CorMedix
◘ Geistlich Pharma
◘ TauroPharm GmbH
◘ Fresenius Medical Care
◘ AstraZeneca Pharma India Ltd.
◘ Glenmark Pharmaceuticals Ltd., Xellia Pharmaceuticals Ltd., and Pfizer.

Note: Major Players are sorted in no particular order.

By Drug Class:

Non-antibiotic
Anti-infective
Antimicrobial

By Pathogenesis:

Contaminated Catheter Hub
Contaminated Infusate
Skin Insertion
Hematogenous

By Source of Infection/Micro-organisms:

Aureus
aeruginsa
CONS
Baumanii
coli
pnemoniae
Candida sp.

By Route of Administration:

Oral
Intravenous

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/4805

The Study Objectives are:

A comprehensive insight into key players operating in the Catheter Related Blood Stream Infection Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2023

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Catheter Related Blood Stream Infection market
Chapter 2: Exclusive Summary - the basic information of the Catheter Related Blood Stream Infection Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Catheter Related Blood Stream Infection
Chapter 4: Presenting the Catheter Related Blood Stream Infection Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2023 - 2030
Chapter 6: Evaluating the leading manufacturers of the Catheter Related Blood Stream Infection market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2023-2030)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/4805

Key Questions Answered:

What is the market size and CAGR of the Catheter Related Blood Stream Infection Market during the forecast period?
How is the growing demand impacting the growth of Catheter Related Blood Stream Infection Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Catheter Related Blood Stream Infection Market?

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.